CCL Products (India) (CCL) — Financial Results

📢 Key Event
CCL Products (India) reported Q1 FY27 results with strong revenue and profit growth, stable EBITDA per kg, and reduced net debt.

🔄 What Changed
Net profit growth of 61.31% and EBITDA growth of 21.84% YoY; net debt reduced to INR963 crores; branded sales target set at INR550-600 crores for FY27; volume growth guidance raised to 15% full-year; capacity expansion deferred until beyond 85% utilization.

🔮 What's Next
INR550-600 crores branded sales target for FY27; 15% full-year volume growth guidance; expansion only beyond 85% capacity utilization; gross debt target of INR1,000 crores; net debt target of INR800 crores; no major capex beyond small upgrades; EBITDA per kg to remain stable at INR135–140; international markets (Percol UK/US) to expand; no M&A plans beyond strategic fits.

💡 Investor Takeaway
Strong profit growth and balance sheet improvement are offset by muted standalone performance and reliance on subsidiaries for future growth, with expansion contingent on capacity utilization.

CCL Products (India) reported Q1 FY27 revenue of ₹1,203.59 crores, up 13.76% YoY, driven by 20% volume growth and strong branded sales targeting INR550-600 crores for FY27. Net profit surged 61.31% to [amount context mismatch]7 crores, while EBITDA rose 21.84% to ₹196.69 crores. EBITDA per kg remains stable at INR135–140, supported by cost-plus pricing and freeze-dried demand. Net debt fell to ₹963 crores from INR1,073 crores, with gross debt targeted at INR1,000 crores by FY27. Capacity utilization is at 77% of 77,000 tons, with expansion planned only beyond 85%. B2C growth hit 26% YoY, and international markets (Percol UK/US) are expanding. No major capex is planned beyond small upgrades, with INR25-50 crores allocated for FY27. Analysts raised concerns on margin pressure from rupee depreciation and El Niño supply risks.

📄 View Original Announcement (PDF)

📊 Stock Analysis — CCL ✨ Ask AI About This

About CCL Products (India) Limited (CCL)

Fast Moving Consumer Goods · Plantation & Plantation Products · Listed on NSE

Market Cap: ₹14,421.68 Cr P/E: 33.3 ROE: 22.0% ROCE: 16.4% Div Yield: 0.53%

View full CCL stock details →

📡 Get AI alerts when CCL files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CCL — Free

💡 Ask AI about this filing

"What is the revenue contribution split between India and international markets?" "How will rupee depreciation impact EBITDA margins in FY27?" "When will capacity expansion beyond 85% utilization begin and what will be the investment?"

Ask AI Free →

📊 More CCL filings

See all CCL filings →

🔥 Also filed on 30 July 2026

PARADEEP Paradeep Phosphates Limited Financial Results SYRMA Syrma SGS Technology Limited Offer Document AYMSYNTEX AYM Syntex Limited Announcement AJANTPHARM Ajanta Pharma Limited Corporate Action GATEWAY Gateway Distriparks Limited Corporate Action GILLETTE Gillette India Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when CCL files new disclosures

Track CCL filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track CCL — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd